DiagnosticsMRI contrast agents detailed in Chengdu Shibeikang patentWork at Chengdu Shibeikang Biological Medicine Technology Co. Ltd. has led to the identification of new gadolinium complexes reported to be potentially useful as magnetic resonance imaging (MRI) contrast agents.